India's most comprehensive portal on pharmaceutical News, …
3 天之前 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
China’s NRDL includes Akeso’s two bispecific antibody drugs ...
1 天前 · Akeso, Inc., a leading biopharmaceutical company, announced that two of its independently developed, globally pioneering bispecific antibody drugs—cadonilimab injection (PD-1/CTLA-4 bispecific antibody) and ivonescimab injection (PD-1/VEGF bispecific antibody)—have both been included in the most ...
Innovent announces first-time inclusion of Sintbilo and new …
21 小时之前 · Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the updated 2024 National ...
Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan receives …
2 天之前 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs, announced that the company received marketing authorization in ...
News - Pharmabiz.com
4 天之前 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Frequency: Weekly (Goes into printing every Tuesday; On stands …
Launched on 21 December 2000, Chronicle Pharmabiz is the No. 1 Pharma news weekly in the South Asian markets; with a target readership that includes 100% coverage of top and middle management pharma professionals across the region.
About Us - Pharmabiz.com
Mr. Sanjiv D Kaul, is currently the management advisor to ChrysCapital,a leading international consulting firm based in New Delhi.He is the former vice-president and head of corporate affairs, Ranbaxy Laboratories Limited and has been the key driver for Ranbaxy's aggressive internationalisation drive in markets as varied as Africa, Commonwealth of Independent States, Asia - Pacific and China ...
Zai Lab, Pfizer enter collaboration on novel antibacterial drug …
2024年11月23日 · Zai Lab (Zai Lab) and Pfizer announced a strategic collaboration for the novel antibacterial drug Xacduro (sulbactam-durlobactam) in mainland China. Pfizer’s affiliated companies will be exclusively authorized to undertake and perform certain commercialization activities for Xacduro in mainland ...
Editorial - Pharmabiz.com
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Pharma exports grew 8.2% in nine months ending December - Pharmabiz.com
2024年1月18日 · Pharma exports grew 8.2% in nine months ending December: Gireesh Babu, New Delhi Thursday, January 18, 2024, 08:00 Hrs [IST] Exports of drugs and pharmaceuticals during the nine months ended December, 2023 have registered a growth of 8.20 per cent, as compared to the same period of previous fiscal year.